Skip to main content
. 2021 Oct 11;14(10):1031. doi: 10.3390/ph14101031

Table 2.

Summary of published studies on epileptic seizures in patients with MS.

Type of Study Number of Patient with MS Patients with Seizures
(Percentage)
Predominant Seizure Type Seizure Occurrence at MS Onset Seizure Occurrence before MS Onset Seizure Occurrence after MS Onset Ref.
Simple Partial Complex Partial Secondary Generalized
(sGTCS)
Generalized Tonic Clonic Status Epilepticus
Cohort 5041 102 (2%)
In 67 patients (1.3%), epileptic seizure could not be explained by any cause other than MS
34 (50.7%) Less frequent 28 (41.8%) 33 (49.3%) 18 (26.9%) 7 cases 26 case 69 case [28]
Retrospective review of the records 310 10 (3.2%) 2 1 case of simple partial 6 2 2 cases of sGTCS 4 cases Not reported Not reported [26]
Retrospective registered-based study 14,545 Cumulative incidence: 502 (3.5%)(CI 3.17–3.76)
The 5-year prevalence: 1.7% (CI 1.54–1.98)
Single seizure was present in 3.0% (CI 2.77–3.32) of patients with MS 0.48% Not reported Not reported Not reported [52]
Systematic review 32 studies Incidence: 2.28% (CI: 1.11–3.44%), at the range of 0.65–5.97%
Prevalence: 3.09% (CI: 2.01–4.16%) at the range of 0.89–8.06%
Not reported Not reported Not reported Not reported Not reported Not reported Not reported Not reported [29]
Retrospective review of the records 1267 * 22 (1.74%) Focal onset in 17 patients (77.3%) 14 out of 17 patients with MS (82.4%) 5 (22.7%) 3 (13%) - 2 (9.1%) 16 (72.7%) [51]
Cohort 428 13 (3%) 10 (77%) Half of patient with focal seizure (38.5%) 3 (23%) 0 4 (31%) - 8 ** [44]
Retrospective cross-sectional epidemiological study 431 19 (4.4%)
14 cases with active epilepsy
4 cases 3 cases 11 cases - 5 (36%) 2 1 11 cases [56]

* The first appearance of seizures for four patients (18.2%) could not be explained by the assessment of their medical records. ** One remaining patient was considered as clinically isolated syndrome. CI: 95% confidence interval; sGTCS: Secondary generalized tonic clonic seizure.